(Q35579593)

9 August 2017

1 reference

title

Role of the androgen receptor axis in prostate cancer (English)

1 reference

9 August 2017

1 reference

Zoran Culig

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

issue

5 Suppl 1

1 reference

9 August 2017

page(s)

21-26

1 reference

Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Androgen receptors in endocrine-therapy-resistant human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Activation of the human androgen receptor through a protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Interleukin-6: a candidate mediator of human prostate cancer morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Interleukin-6 is an autocrine growth factor in human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2803%2900698-8

7 January 2021

10.1016/S0090-4295(03)00698-8

Identifiers

DOI

1 reference

9 August 2017

1 reference